Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
about
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast CancerPrevalence of the TP53 p.R337H mutation in breast cancer patients in BrazilTumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.Germline TP53 variants and susceptibility to osteosarcoma.Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutationTiming of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Routine TP53 testing for breast cancer under age 30: ready for prime time?Clinical implications of germline mutations in breast cancer: TP53.Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.Frequent occurrence of gastric cancer in Asian kindreds with Li-Fraumeni syndrome.Breast and ovarian cancer penetrance of BRCA1/2 mutations among Hong Kong women.Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.
P2860
Q27023165-B8E3D3E4-B5D1-42B6-BCF6-85A59217F1BBQ33768942-EBE67A5E-AB5D-4627-9C29-6A1DF0160FA6Q34324683-A60F1CCD-041E-40FB-A5EA-EFDF1EEB9900Q35558112-3E651474-45F6-47E9-A0F2-D53BF14091E4Q36294747-457F932F-0BB1-4BC9-BC98-6A96FEA94B7EQ37011925-EAD1C9DA-816E-43CD-AFEE-5ECF6707C14DQ37395951-9E0A7AF9-66D6-4279-8C3A-01EEAAEC12AAQ37716648-46E873BA-73EE-4072-8E99-C4B32FE1819DQ38262476-E6FE692F-10DD-4061-830D-9CF3EE8A7E76Q42181679-C55F07A6-CF02-4FE4-8D48-CA4C85CA834FQ47317433-8844019F-A306-49A4-842E-BEA67DAC8232Q47607437-A001A618-C5AE-495D-9430-A19ADC099213Q47763856-F70966EC-9ED3-473B-840B-A57CB696B5C5Q53082848-B5BC0DC2-A42A-4FA8-B045-9E0AE02B0C5CQ55420639-C7B3D570-8D53-4D63-A3FE-7A54E2A5F27CQ55459904-31607169-0528-4BAC-A512-8F34FA32CD1D
P2860
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comparable frequency of BRCA1, ...... -onset breast cancer patients.
@ast
Comparable frequency of BRCA1, ...... -onset breast cancer patients.
@en
type
label
Comparable frequency of BRCA1, ...... -onset breast cancer patients.
@ast
Comparable frequency of BRCA1, ...... -onset breast cancer patients.
@en
prefLabel
Comparable frequency of BRCA1, ...... -onset breast cancer patients.
@ast
Comparable frequency of BRCA1, ...... -onset breast cancer patients.
@en
P2093
P2860
P356
P1476
Comparable frequency of BRCA1, ...... y-onset breast cancer patients
@en
P2093
Cheng-Har Yip
Daphne S C Lee
Hany Ariffin
In Nee Kang
Kavitta Sivanandan
Kin Fah Chin
Nur Aishah Mohd Taib
Peter Kang
Soo-Hwang Teo
Sook-Yee Yoon
P2860
P2888
P356
10.1186/BCR3172
P577
2012-04-16T00:00:00Z
P5875
P6179
1008976679